s6y
Company name or ticker
Search
Neal James R
3
Processa Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Filed
Thursday, July 21, 2022
Period
Jul 19, 2022
Accession number
0001567619-22-014304
Documents
FORM 3
3
POWER OF ATTORNEY
EX-24.1
On sec.gov
Filing index
All files
Complete submission text
SGML header